Future of Neuromodulation IP: Quantifying Patent ROI, & AI/ML Integration Risks in Stimulation Timing Technologies

The US-India Advantage: Strategic Work Distribution

Our patenting service model strategically distributes patent work between US and Indian professionals to optimize both quality and cost-effectiveness.

US-based registered patent attorneys and agents maintain direct client relationships and provide strategic oversight, while our Indian team contributes technical expertise and support services that enhance the overall patent prosecution process.

The US patenting team provides:

• Direct client communication and strategic guidance

• Final review and quality assurance of all submissions

• USPTO communications management

• Strategic decision-making and recommendations

• Direct representation before the USPTO

The Indian patenting team contributes:

• Technical research and analysis

• Prior art searching and analysis

• Draft amendment of patent application

• Office action response support

• Patent drawings and illustrations

• Technical specifications development

Why Us
Cost-Effective Service Delivery & Optimized Resource Allocation

Our working model achieves cost savings through:

• Strategic distribution of technical tasks

• Efficient workflow management

• Time zone advantages for faster turnaround

• Reduced overhead costs

• Economies of scale

Transparent Pricing Structure

We offer clear pricing models that reflect our cost advantages:

• Fixed-fee arrangements for standard services

• Customized packages for portfolio clients

• Volume-based discounting

• Flexible engagement models

NEST coordinates on critical technologies & inventions including:

• Artificial Intelligence (including GPAI participation)

• Quantum Technology 5G/6G telecommunications

• Semiconductors

• Biotechnology & Healthcare

• Green energy & Green Hydrogen

• Critical Minerals Digital Public Infrastructure (DPI) Space & Geospatial Technologies.

Neuromodulation technology has transitioned from open-loop, programmed stimulation to adaptive, physiologically-responsive systems where therapeutic delivery is contingent upon precise temporal alignment with neural dynamics. This evolution is reflected in the patent classification structure through the emergence of A61N1/36167 – a specialized subclass addressing timing parameters, particularly stimulation onset mechanisms.

• A61N1/36: Alternating/intermittent currents for stimulation

• ↳ A61N1/3605: Implantable neurostimulators

• ↳ A61N1/36128: Control systems

• ↳ A61N1/36146: Control systems specified by stimulation parameters

• ↳ A61N1/36167: Timing, e.g. stimulation onset

This taxonomy distinguishes temporal control from adjacent parameters such as frequency (A61N1/36171), pulse width (A61N1/36175), and burst characteristics (A61N1/36178). The differentiation is non-trivial: while conventional parameters define what energy is delivered, A61N1/36167 inventions define when delivery commences relative to endogenous or exogenous events.

Patent practitioners worldwide must navigate technical complexity, prosecution challenges, and cross-disciplinary prior art to secure effective protection. As latency requirements shrink from milliseconds to microseconds and algorithms grow more adaptive, this subclass will increasingly define competitive advantage in neurostimulation markets.

Future research should quantify therapeutic outcomes correlation with specific timing parameters to strengthen patent validity and guide standard development. The intersection of temporal control with AI/ML algorithms presents both opportunity and uncertainty, requiring close monitoring of eligibility jurisprudence across jurisdictions.

NEST: Achieving Strategic Autonomy in Emerging Tech- Quantifying Patent ROI, & AI/ML Integration Risks in Stimulation Timing Technologies